News

The company’s porcine liver is for use with partner OrganOx’s extracorporeal liver cross-circulation (ELC) system in patients ...
In the phase 1 trial, up to twenty patients with ACLF and hepatic encephalopathy and ineligible for transplant will be ...
CAMBRIDGE, Mass. & OXFORD, England, April 15, 2025--eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for ...
The FDA has cleared the first clinical trial to test genetically engineered pig livers in patients who have acute-on-chronic liver failure. The trial will evaluate the use of a Egenesis porcine liver ...
A genetically modified porcine liver has been successfully transplanted into a human subject, constituting a historic precedent in the field of organ transplantation. The liver demonstrated functional ...
‘It is the first study to demonstrate that a genetically modified porcine liver can survive and exert basic metabolic functions - albumin and bile production - in the human body.’ Liver ...
A multidisciplinary team from China has successfully transplanted a gene-modified pig liver into a human recipient diagnosed with brain death. During a 10-day observation period, the porcine liver ...